How many insider trades does FilingIQ track for SMNR?

FilingIQ tracks 3 Form 4 insider transactions for SMNR (Semnur Pharmaceuticals, Inc.), covering filings from Sep 23, 2025 onwards. 1 of those were filed in the last 90 days.

Are SMNR insiders net buyers or net sellers?

Across the full Form 4 history for SMNR, 0 transactions (0%) were open-market purchases and 2 (67%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SMNR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SMNR in?

Semnur Pharmaceuticals, Inc. (SMNR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $253.23M.

SMNR insider trading

OTC Markets OTCPK Healthcare

Semnur Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 67%

Market cap

$253.23M

About Semnur Pharmaceuticals, Inc.

Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company.

Company website: www.semnurpharma.com

SMNR insider activity at a glance

FilingIQ has scored 3 insider transactions for SMNR since Sep 23, 2025. The most recent filing in our index is dated Jun 15, 2026.

Across the full history, 0 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SMNR insider trades is 57.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SMNR trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,213

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

KYMR 178

Kymera Therapeutics, Inc.

First Tracks Biotherapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for SMNR?: FilingIQ tracks 3 Form 4 insider transactions for SMNR (Semnur Pharmaceuticals, Inc.), covering filings from Sep 23, 2025 onwards. 1 of those were filed in the last 90 days.
Are SMNR insiders net buyers or net sellers?: Across the full Form 4 history for SMNR, 0 transactions (0%) were open-market purchases and 2 (67%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SMNR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SMNR in?: Semnur Pharmaceuticals, Inc. (SMNR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $253.23M.

Methodology & sources

Every SMNR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.